Literature DB >> 19909890

Use of antibacterial agents in renal failure.

Brett Gilbert1, Paul Robbins, Lawrence L Livornese.   

Abstract

This article provides background information on the pharmacokinetics of antibacterial agents in patients who have normal and impaired renal function. Tables are provided to allow quick determination of appropriate dosages for varying degrees of renal failure. The use of serum levels; newer strategies for cefazolin, vancomycin and aminoglycoside dosing; methods of dialysis and associated antibiotics dosage adjustments, and antibiotic toxicity in renal failure are reviewed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19909890     DOI: 10.1016/j.idc.2009.06.009

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  4 in total

Review 1.  Antibiotics in dental practice: how justified are we.

Authors:  Sukhvinder S Oberoi; Chandan Dhingra; Gaurav Sharma; Divesh Sardana
Journal:  Int Dent J       Date:  2014-12-16       Impact factor: 2.607

Review 2.  Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact.

Authors:  Daniel Gonzalez; Gauri G Rao; Stacy C Bailey; Kim L R Brouwer; Yanguang Cao; Daniel J Crona; Angela D M Kashuba; Craig R Lee; Kathryn Morbitzer; J Herbert Patterson; Tim Wiltshire; Jon Easter; Scott W Savage; J Robert Powell
Journal:  Clin Transl Sci       Date:  2017-08-10       Impact factor: 4.689

3.  Treatment of recurrent urinary tract infections in anuric hemodialysis patient, do we really need antimicrobial urinary concentration?

Authors:  Wasim S El Nekidy; Derrick Soong; Mohamad Mooty; Islam M Ghazi
Journal:  IDCases       Date:  2020-03-21

4.  Oral and maxillofacial surgery in patients undergoing dialysis for advanced renal disease: report of five cases.

Authors:  Yumi Mochizuki; Hiroyuki Harada; Misaki Yokokawa; Naoya Kinoshita; Kazumasa Kubota; Tomokazu Okado; Haruhisa Fukayama
Journal:  BMC Oral Health       Date:  2018-10-19       Impact factor: 2.757

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.